Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

244.54
-6.5600-2.61%
Pre-market: 245.000.4600+0.19%07:00 EDT
Volume:1.19M
Turnover:293.91M
Market Cap:15.87B
PE:16.72
High:250.64
Open:249.48
Low:244.49
Close:251.10
52wk High:266.38
52wk Low:123.88
Shares:64.91M
Float Shares:62.69M
Volume Ratio:0.62
T/O Rate:1.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.63
EPS(LYR):-5.8403
ROE:22.11%
ROA:6.86%
PB:3.31
PE(LYR):-41.87

Loading ...

Jazz Pharmaceuticals Plc : Baird Raises Target Price to $280 from $252

THOMSON REUTERS
·
Aug 04

Analysts Offer Insights on Healthcare Companies: HealthStream (HSTM) and Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
Aug 04

Jazz Pharmaceuticals PLC Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

GUIDANCE: (JAZZ) Jazz Pharmaceuticals Expects Full Year 2026 Revenue Range $4.60B - $4.75B, vs. FactSet Est of $4.51B

MT Newswires Live
·
Aug 04

Jazz Q2 FY26 GAAP EPS Rises 16% to $2.78; Revenue Increases 16% to $1.21 Billion

Reuters
·
Aug 04

Jazz Pharmaceuticals Q2 Adjusted EPS USD 5.71 Vs. IBES Estimate USD 6.18

Reuters
·
Aug 04

Jazz Pharmaceuticals Q2 EPS USD 2.78

THOMSON REUTERS
·
Aug 04

Jazz Pharmaceuticals Has Several Growth Options Beyond Marketed Drugs, RBC Says

MT Newswires Live
·
Jul 31

Werewolf Therapeutics Posts Q2 Profit on Jazz Asset Sale

Reuters
·
Jul 31

Should Anticipated Earnings Beat and Employer Award Recognition Require Action From Jazz Pharmaceuticals (JAZZ) Investors?

Simply Wall St.
·
Jul 29

Earning Preview: Jazz Pharmaceuticals PLC revenue is expected to increase by 6.51%, and institutional views are bullish

Earnings Agent
·
Jul 27

Jazz Pharmaceuticals (JAZZ) Stock Still Looks Cheap As Shares Jumped 115%

Simply Wall St.
·
Jul 26

Jazz Pharmaceuticals Held Annual Shareholder Meeting in Dublin

Reuters
·
Jul 24

Jazz Pharmaceuticals Plc : Raymond James Raises Target Price to $275 from $239

THOMSON REUTERS
·
Jul 21

Jazz Pharmaceuticals to Report Q2 Financial Results After U.S. Market Close

Reuters
·
Jul 21

Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026

THOMSON REUTERS
·
Jul 21

Jazz Pharmaceuticals is Maintained at Buy by Needham

Dow Jones
·
Jul 20

Did Jazz’s Sleep and Oncology Pipeline Momentum Just Shift Jazz Pharmaceuticals' (JAZZ) Investment Narrative?

Simply Wall St.
·
Jul 20

Apple, Jazz, Moody’s, AEP, 3M Trending With Analysts

TIPRANKS
·
Jul 18

Jazz Pharmaceuticals Initiated at Buy by Canaccord Genuity

Dow Jones
·
Jul 17